ATE483979T1 - Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa - Google Patents
Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoaInfo
- Publication number
- ATE483979T1 ATE483979T1 AT05770407T AT05770407T ATE483979T1 AT E483979 T1 ATE483979 T1 AT E483979T1 AT 05770407 T AT05770407 T AT 05770407T AT 05770407 T AT05770407 T AT 05770407T AT E483979 T1 ATE483979 T1 AT E483979T1
- Authority
- AT
- Austria
- Prior art keywords
- cancer
- anln
- rhoa
- small cell
- cell lung
- Prior art date
Links
- 208000002154 non-small cell lung carcinoma Diseases 0.000 title abstract 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 title abstract 3
- 101000732632 Homo sapiens Anillin Proteins 0.000 title abstract 2
- 101150111584 RHOA gene Proteins 0.000 title abstract 2
- 230000003993 interaction Effects 0.000 title abstract 2
- 102100022387 Transforming protein RhoA Human genes 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 5
- 201000011510 cancer Diseases 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 5
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002265 prevention Effects 0.000 abstract 2
- 102100033393 Anillin Human genes 0.000 abstract 1
- 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60056104P | 2004-08-10 | 2004-08-10 | |
| PCT/JP2005/014887 WO2006016697A1 (en) | 2004-08-10 | 2005-08-09 | Non-small cell lung cancer-related gene, anln, and its interactions with rhoa |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE483979T1 true ATE483979T1 (de) | 2010-10-15 |
Family
ID=35355888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05770407T ATE483979T1 (de) | 2004-08-10 | 2005-08-09 | Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090297500A1 (enExample) |
| EP (1) | EP1787122B1 (enExample) |
| JP (1) | JP4874234B2 (enExample) |
| AT (1) | ATE483979T1 (enExample) |
| DE (1) | DE602005024021D1 (enExample) |
| WO (1) | WO2006016697A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8060348B2 (en) | 2006-08-07 | 2011-11-15 | General Electric Company | Systems for analyzing tissue samples |
| US8131476B2 (en) | 2006-08-07 | 2012-03-06 | General Electric Company | System and method for co-registering multi-channel images of a tissue micro array |
| CA2669600A1 (en) * | 2006-11-13 | 2008-05-29 | Source Precision Medicine, Inc. D/B/A Source Mdx | Gene expression profiling for identification, monitoring, and treatment of lung cancer |
| US20100184047A1 (en) * | 2007-03-30 | 2010-07-22 | Oncotherapy Science, Inc. | Screening and therapeutic method for nsclc targeting the cdca8-aurkb complex |
| EP2161577A1 (en) * | 2008-09-01 | 2010-03-10 | Atlas Antibodies AB | ANLN protein |
| US20120041274A1 (en) | 2010-01-07 | 2012-02-16 | Myriad Genetics, Incorporated | Cancer biomarkers |
| US9125899B1 (en) | 2010-06-17 | 2015-09-08 | Stc.Unm | Modulators of GTPases and their use |
| EP3812469A1 (en) * | 2010-07-07 | 2021-04-28 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| MX355020B (es) | 2010-07-09 | 2018-04-02 | Somalogic Inc | Biomarcadores de cancer de pulmon y usos de los mismos. |
| WO2012030840A2 (en) | 2010-08-30 | 2012-03-08 | Myriad Genetics, Inc. | Gene signatures for cancer diagnosis and prognosis |
| EP2755026B1 (en) | 2011-09-09 | 2021-10-27 | Konica Minolta, Inc. | Method for staining tissue |
| KR101921945B1 (ko) * | 2011-10-24 | 2018-11-26 | 소마로직, 인크. | 폐암 바이오마커 및 그것의 용도 |
| JP5806168B2 (ja) * | 2012-06-19 | 2015-11-10 | 国立大学法人 岡山大学 | 抗浸潤薬の新規スクリーニング法 |
| WO2014078700A1 (en) | 2012-11-16 | 2014-05-22 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| EP3143160B1 (en) | 2014-05-13 | 2019-11-06 | Myriad Genetics, Inc. | Gene signatures for cancer prognosis |
| WO2017213851A1 (en) * | 2016-06-09 | 2017-12-14 | The Board Of Regents Of The University Of Texas System | Inhibitory rna-based therapeutics targeting anln for cancer treatment |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200413725A (en) * | 2002-09-30 | 2004-08-01 | Oncotherapy Science Inc | Method for diagnosing non-small cell lung cancers |
| EP1620573A4 (en) * | 2003-04-15 | 2006-12-20 | Avalon Pharmaceuticals | DETERMINATION OF CANCER-ASSOCIATED GENES AND THERAPEUTIC OBJECTS USING MOLECULAR CYTOGENETIC PROCEDURES |
-
2005
- 2005-08-09 EP EP05770407A patent/EP1787122B1/en not_active Expired - Lifetime
- 2005-08-09 DE DE602005024021T patent/DE602005024021D1/de not_active Expired - Lifetime
- 2005-08-09 JP JP2007506605A patent/JP4874234B2/ja not_active Expired - Fee Related
- 2005-08-09 WO PCT/JP2005/014887 patent/WO2006016697A1/en not_active Ceased
- 2005-08-09 AT AT05770407T patent/ATE483979T1/de not_active IP Right Cessation
- 2005-08-09 US US11/573,393 patent/US20090297500A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006016697A1 (en) | 2006-02-16 |
| JP4874234B2 (ja) | 2012-02-15 |
| JP2008510126A (ja) | 2008-04-03 |
| DE602005024021D1 (de) | 2010-11-18 |
| US20090297500A1 (en) | 2009-12-03 |
| EP1787122A1 (en) | 2007-05-23 |
| EP1787122B1 (en) | 2010-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE483979T1 (de) | Gen anln in verbindung mit nicht-kleinzelligem lungenkrebs und seine wechselwirkungen mit rhoa | |
| FR21C1064I2 (fr) | Compositions et procedes de traitement de troubles impliquant une proliferation cellulaire | |
| IL258880A (en) | Diarylhydantoin compounds | |
| WO2009049214A3 (en) | Inhibition and treatment of prostate cancer metastasis | |
| TW200626174A (en) | Biomarkers for pre-selection of patients for anti-IGF1R therapy | |
| TW200600785A (en) | Method for diagnosing non-small cell lung cancer | |
| WO2014144657A3 (en) | Compositions and methods for cancer prognosis | |
| NZ591613A (en) | Polymorphic marker rs965513 for risk assessment of thyroid cancer | |
| CY1108092T1 (el) | Ενωσεις και μεθοδοι για την αναστολη της μιτωτικης προοδου με την αναστολη της κινασης aurora | |
| WO2020239895A3 (en) | Detection of colorectal cancer | |
| DE602004015811D1 (de) | Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden | |
| WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
| WO2010042933A3 (en) | Inhibition and treatment of prostate cancer metastasis | |
| MX2010005768A (es) | Composiciones y métodos para inhibir la activación del arnbc-dependiente de la proteina de la kinasa y la inhibición del crecimiento tumoral. | |
| MX2009005058A (es) | Metodos para tratar, diagnosticar o detectar cancer. | |
| WO2007034221A3 (en) | Non small cell lung cancer therapy prognosis and target | |
| BRPI0403169A (pt) | Prognósticos de câncer colorretal | |
| ATE502025T1 (de) | Arylcarboxamide und ihre verwendung als antitumormittel | |
| DE602006005084D1 (de) | Verfahren zur vorhersage und verhinderung der resistenz gegen taxoid-verbindungen | |
| MXPA05004971A (es) | Pronostico para malignidad hematologica. | |
| MX2008016269A (es) | Fermentacion y purificacion de cromoproteinas actinomadura y especies relacionadas. | |
| WO2013066485A3 (en) | Compositions and methods for treatment of metastatic cancer | |
| TW200716132A (en) | Novel chemical compounds | |
| WO2006086772A3 (en) | DIAGNOSING AND TREATING CANCER USING β-CATENIN SPLICE VARIANTS | |
| ATE533861T1 (de) | Mipol1-etv1-gen-neuanordnungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |